Otriven ® contains the active substance xylometazoline hydrochloride .
It is a medicine of the group of rhinologics.
These are medicines that can be prescribed for use in the nose when you have a cold.
The nose should be thoroughly cleaned before using Otriven ® Nasal Drops. Blowing is enough. The drops can then be instilled into each nostril with the head bowed back. Nasal drops should only be used by one person for hygienic reasons and to prevent infections.
Otriven ® should not be used for more than a week. A prolonged use should be discussed with a doctor. If this is not the case, a break of several days should be taken after seven days before restarting with Otriven ® Nasal Drops.
Otriven ® is less suitable for the treatment of chronic colds, as it can lead to a loss of the nasal mucosa if used too long. The recommended daily dose is one to two drops in each nostril up to three times.
As mentioned above, Otriven® contains the active substance xylometazoline . It is a sympathomimetic, an agent that activates the sympathetic nervous system.
Because it only binds to the alpha receptor, it has a vasoconstrictor component in the nasal mucosa. The mucous membrane is less perfused and swells off. Within 5 to 10 minutes after using the nose drops, the effect occurs. Improved nasal breathing through mucosal swelling and better secretion drainage are the result of Otriven® nasal drops. Xylometazoline is usually used in salt form. This is possible by means of hydrochloride.
Otriven® nose drops are over-the-counter and can be purchased at the pharmacy.
Otriven® is used in the following conditions: rhinitis vasomotorica: a seizure syndrome occurring in fits; Allergic rhinitis: allergic rhinitis; Sinusitis and otitis media associated with runny nose: by facilitating the drainage of the nasal secretion, the Eustachian tube or the sinuses can be better ventilated again and a healing occurs more quickly.
If one of the following applies, Otriven® must not be used with:
Otriven® may only be used in consultation with the attending physician for the following conditions:
Otriven® 0.05% must not be prescribed in infants and toddlers under the age of two years. For this age group, an Otriven® containing 0.025% xylometazoline hydrochloride was specifically made. Children from two to six years of age may use Otriven® 0.05%.
Long-term use and too high a daily dose should be avoided. Long-term use and higher doses should only be under medical supervision.
For schoolchildren and adults, Otriven® nasal drops containing 0.1% xylometazoline hydrochloride are on the market. Again, the recommended daily allowance should not be exceeded to avoid any unwanted drug reactions.
Otriven® nose drops have no effect on the ability to drive.
Like other medicines, Otriven® can cause adverse drug reactions.
The most common side effect is an increasing swelling of the nasal mucosa after the active ingredient has decayed. Occasionally occurring side effects include: sneezing, nose bleeding, increased blood pressure, palpitations, rapid heartbeat, rash or itching. Less common are headaches, insomnia or tiredness after Otriven®. Also noteworthy are the unwanted drug reactions, which occur only very rarely: Hallucinations or convulsions can occur in children in the rarest of cases. Burning or dryness of the nasal mucosa can occur with too long, frequent use as well as with too high a dosage. The nasal mucous membrane can also increase swelling. The appearance occurs in the so-called rhinitis medicamentosa. Increased drug use triggers these symptoms. If the medication is not discontinued after the onset of these symptoms, lasting damage (barking) in the nasal mucosa may occur after continued use. The disease is also referred to as rhinitis sicca.
If side effects occur, they should be reported to the doctor. This decides on the countermeasures that should be taken.
If you experience sudden or severe side effects such as excessive blood pressure, severe headache or a hypersensitivity reaction, you should inform a doctor immediately.
A quick action is important to avoid any serious consequences.
The attending physician should be aware of any medication taking place recently or recently. Caution should be exercised with the concomitant use of Otriven® and mood-enhancing medicines, such as MAOIs or tricyclic antidepressants, as well as antihypertensive drugs. It can come to a momentous increase in blood pressure.
The clinical picture of xylometazoline hydrochloride intoxication is varied.
Phases of activation may overlap with phases of central nervous system inhibition. Especially in children, it can lead to convulsions, coma, slow pulse or respiratory arrest after too high a dose. A rapidly occurring high blood pressure is quickly replaced by the blood pressure drop again. Other signs of overdose include hallucinations, anxiety, inner agitation, narrowing of the pupil (myosis), dilation of the pupil (mydirasis), fever, sweating, pallor, nausea or vomiting, cardiac arrhythmias.
If poisoned with Otriven®, seek medical advice immediately. The fastest possible treatment and monitoring in the hospital are necessary.
Otriven ® should be stored at room temperature in its original packaging, protected from moisture and light. Generally, it should be kept out of the reach of children.
The drug may not be used after the expiration date. It should not be disposed of in household waste or wastewater.